Company: PTPI
Filing Date: 2025-03-07
Form Type: PRE 14A
Source: 0001104659-25-021794
Chunk: 74

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-07
Form: PRE 14A
Chunk 74
---
ED IN FAVOR THEREOF
UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY.

46

OTHER MATTERS</div>

The Board of Directors knows
of no other business which will be presented to the Special Meeting. If any other business is properly brought before the Special Meeting,
proxies will be voted in accordance with the judgment of the persons named therein.

<div align='center'>STOCKHOLDER COMMUNICATIONS TO THE BOARD</div>

The Company has a process
for stockholders who wish to communicate with the Board, including any Board committee, individual director or the Chairman. Stockholders
who wish to communicate with the Board, any Board Committee or any individual director may do so by writing to the Company’s President
and Chief Commercial Officer, Fady Boctor, at 1185 Avenue of the Americas, 3rd Floor, New York, New York 10036. In general, any stockholder
communication delivered to our President and Chief Commercial Officer for forwarding to the Board, the Chairman or a specified group
of Board members will be forwarded in accordance with the stockholder’s instructions. However, our President and Chief Commercial
Officer reserves the right not to forward to Board members any abusive, threatening or otherwise inappropriate materials.

<div align='center'>STOCKHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR</div>

To be considered for inclusion
in the proxy statement relating to our 2025 annual meeting of stockholders (“2025 Annual Meeting”), pursuant to Rule 14a-8
of the Exchange Act, we must receive stockholder proposals (other than for director nominations) not less than 120 calendar days before
the date of the Company’s proxy statement released to stockholders in connection with the previous year’s special meeting.
To be considered for presentation at the 2025 Annual Meeting, outside of the requirements of Rule 14a-8 of the Exchange Act, although
not included in the proxy statement, proposals must be received not less than ninety (90) nor more than one hundred twenty (120) days
prior to the one year anniversary of our 2024 annual meeting of stockholders (“2024 Annual Meeting”), provided, however,
that in the event that the 2025 Annual Meeting is called for a date that is not within thirty (30) days before or after the date that
is one year from the 2024 Annual Meeting date, notice by the stockholder in order to be timely must be so received not later than the
close